PhD Candidate in Rheumatology and Clinical Immunology | PhD (m/f/d) Rheumatology & Clinical Immunology

Universitätsklinikum Schleswig-Holstein

Lübeck, Schleswig-Holstein, Deutschland
Published Mar 25, 2026
Full-time
Permanent

Job Summary

This doctoral position is part of the DFG-funded Research Unit 5930, a multidisciplinary collaboration focused on identifying antibodies targeting G protein-coupled receptors (GPCR) in vascular diseases. As a PhD candidate, you will work on subproject P03, specifically aiming to generate monoclonal antibodies from human samples of patients with pulmonary arterial hypertension and atherosclerosis. Your day-to-day activities will involve a mix of wet and dry lab work, including single-cell RNA sequencing of B cells and spatial transcriptomics. You will be responsible for recombinant expression of B cell receptors and the subsequent characterization of antibodies. This role is highly attractive for researchers seeking a structured doctoral program within a prestigious national research group. It offers an interdisciplinary environment with access to state-of-the-art methodological facilities, scientific networking opportunities, and participation in international conferences, all while being supervised by leading experts in clinical immunology and biochemistry.

Required Skills

Education

Master’s degree or equivalent in life sciences, biology, biochemistry, or a related discipline, fulfilling the formal requirements for doctoral enrollment at the University of Lübeck.

Experience

  • Professional experience in experimental scientific work within life sciences
  • Experience in molecular biology techniques such as sequencing or transcriptomics
  • Experience in independent research and structured data analysis
  • Experience working within collaborative, interdisciplinary research teams

Languages

English (Fluent)

Additional

  • Must fulfill formal requirements for enrollment as a doctoral candidate at the University of Lübeck. Position is based in Lübeck, Germany. Funding is provided for up to four years.